These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
154 related articles for article (PubMed ID: 9569210)
1. Reduced protein C levels--a contributory factor for stroke in sickle cell disease. Khanduri U; Gravell D; Christie BS; Al Lamki Z; Zachariah M; Cherian E Thromb Haemost; 1998 Apr; 79(4):879-80. PubMed ID: 9569210 [No Abstract] [Full Text] [Related]
2. Plasma protein C levels in children with sickle cell disease. Lane PA Am J Pediatr Hematol Oncol; 1991; 13(3):365-6. PubMed ID: 1793164 [No Abstract] [Full Text] [Related]
3. Anti-thrombin III deficiency in Nigerian children with sickle cell disease. Possible role in the cerebral syndrome. Onyemelukwe GC; Jibril HB Trop Geogr Med; 1992 Jan; 44(1-2):37-41. PubMed ID: 1496720 [TBL] [Abstract][Full Text] [Related]
4. Protein C and protein S activity in sickle cell disease and stroke. Tam DA J Child Neurol; 1997 Jan; 12(1):19-21. PubMed ID: 9010791 [TBL] [Abstract][Full Text] [Related]
5. Protein C deficiency and stroke in early life. Kennedy CR; Warner G; Kai M; Chisholm M Dev Med Child Neurol; 1995 Aug; 37(8):723-30. PubMed ID: 7672469 [TBL] [Abstract][Full Text] [Related]
9. [Cerebrovascular occlusion in children with sickle cell anemia. Thirteen cases seen in Kinshasa, Zaïre (author's transl)]. Omanga U; Shako D; Ntihinyurwa M; Mashako M Ann Pediatr (Paris); 1982 May; 29(5):371-4. PubMed ID: 7103357 [No Abstract] [Full Text] [Related]
14. Significance of reduced protein C in patients with acute stroke and unfavourable prognosis. D'Angelo A; Landi G; Candelise L; Nobile Orazio E; Viganò-D'Angelo S; Mannucci PM Thromb Haemost; 1988 Oct; 60(2):345. PubMed ID: 3146149 [No Abstract] [Full Text] [Related]
15. The natural history of stroke in sickle cell disease. Powars D; Wilson B; Imbus C; Pegelow C; Allen J Am J Med; 1978 Sep; 65(3):461-71. PubMed ID: 717414 [No Abstract] [Full Text] [Related]
16. Basic parameters of thrombophilia in ocular Behçet disease with posterior segment involvement. Citirik M; Haznedaroglu IC; Teberik K; Soykan E; Zilelioglu O Br J Ophthalmol; 2009 Oct; 93(10):1382-6. PubMed ID: 19635722 [TBL] [Abstract][Full Text] [Related]
17. Neurologic complications following bone marrow transplantation for sickle cell disease. Abboud MR; Jackson SM; Barredo J; Holden KR; Cure J; Laver J Bone Marrow Transplant; 1996 Mar; 17(3):405-7. PubMed ID: 8704695 [TBL] [Abstract][Full Text] [Related]
18. Exchange transfusion in the management of CNS crisis in sickle cell disease. Jayabose S; Sheikh F; Mitra N Clin Pediatr (Phila); 1983 Nov; 22(11):776-7. PubMed ID: 6617059 [No Abstract] [Full Text] [Related]
19. Natural coagulation inhibitors (protein C, protein S, antithrombin) in patients with sickle cell anemia in a steady state. Bayazit AK; Kilinç Y Pediatr Int; 2001 Dec; 43(6):592-6. PubMed ID: 11737735 [TBL] [Abstract][Full Text] [Related]
20. Protein C activity in Gabonese children with sickle cell disease. Blavy G; Gnansounou F; NGou-Milama E Nouv Rev Fr Hematol (1978); 1995; 37(4):251-2. PubMed ID: 8904207 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]